Qilian International Holding Group Limited (NASDAQ:QLI) Sees Large Increase in Short Interest

Qilian International Holding Group Limited (NASDAQ:QLI) saw a large growth in short interest in the month of July. As of July 15th, there was short interest totalling 39,900 shares, a growth of 187.1% from the June 30th total of 13,900 shares. Based on an average daily volume of 24,300 shares, the short-interest ratio is presently 1.6 days. Approximately 2.5% of the shares of the company are sold short.

Qilian International Holding Group Stock Up 14.8 %

Shares of NASDAQ QLI traded up $0.84 during midday trading on Thursday, hitting $6.49. 11,316 shares of the company’s stock were exchanged, compared to its average volume of 26,456. Qilian International Holding Group has a 12-month low of $1.78 and a 12-month high of $6.69. The business’s fifty day moving average price is $4.20 and its two-hundred day moving average price is $3.51.

About Qilian International Holding Group

Qilian International Holding Group Limited manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions.